中东和非洲医药合同销售组织市场预测至 2030 年 - 区域分析 - 按服务(商业服务和非商业服务)、模块(联合模块和专用模块)、治疗领域(心血管疾病、肿瘤学、代谢紊乱、神经病学、骨科疾病、传染病等)和最终用户(生物制药公司和制药公司)划分

BMIRE00030179 | Pages: 79 | Pharmaceuticals | May 2024 | Type: Regional | Status: Published
中东和非洲医药合同销售组织市场预计将从 2022 年的 2.639 亿美元增长到 2030 年的 4.6296 亿美元。预计 2022 年至 2030 年的复合年增长率为 7.3%。

新兴市场的扩张推动中东和非洲医药合同销售组织市场

医药合同销售组织 (CSO) 市场的未来轨迹明显受到向新兴市场扩张的战略趋势的影响。随着全球医药格局的扩大,新兴经济体的地位日益突出,CSO 越来越认识到尚未开发的潜力。新兴市场带来了机遇,推动力包括医疗保健意识的提高、中产阶级人口的扩大以及政府对医疗保健基础设施的投资增加。通过将业务扩展到这些新兴市场,CSO 可以利用对医药产品日益增长的需求,并在有望大幅增长的市场中尽早站稳脚跟。然而,这种扩张需要对当地监管环境、文化差异和多样化的医疗保健系统有明智的理解。成功扩张到新兴市场需要采取量身定制的方法,其中 CSO 必须将其战略与每个地区独特的挑战和机遇相结合。此外,这种扩张将 CSO 定位为全球医疗保健生态系统中的关键参与者,有助于收入增长和改善这些不断发展的市场中医疗保健可及性和结果的更广泛目标。从本质上讲,向新兴市场扩张的战略举措是一种前瞻性趋势,反映了制药 CSO 在应对全球化制药格局的复杂性方面的适应性和远见。

中东和非洲制药合同销售组织市场概览

中东和非洲的制药合同销售组织市场分为沙特阿拉伯、南非、阿联酋和 MEA 其他地区。推动市场增长的因素包括数字技术的日益融合以及制药公司对增加产品销售的兴趣日益浓厚。然而,与外包相关的质量问题阻碍了市场增长。阿联酋是该地区的一个发达国家,其医疗保健行业一直表现出显著的增长,这主要得益于人口的增长和对医药产品需求的激增。不断发展的医疗保健行业为制药业提供了重要的增长机会。阿联酋是世界上增长最快的制药业之一,也以采用先进技术而闻名。迪拜工业战略 2030 和阿布扎比愿景 2030 等举措侧重于发展国家制药业,考虑到未来的增长前景、出口潜力以及中长期经济影响。科学研究的重大进展有利于开发和生产具有创新潜力的药物。制药行业的激烈竞争迫使企业尽快将其治疗药物推向市场,以保持市场领先地位。因此,对高效医药产品的需求不断增长、制药公司数量不断增加、传染病和慢性病发病率不断上升以及产品频繁推出,这些都支持了中东和非洲制药业的发展,从而需要使用 CSO 服务,这有利于该地区医药合同销售组织市场的增长。

中东和非洲医药合同销售组织市场收入和预测到 2030 年(百万美元)

中东和非洲医药合同销售组织市场细分

中东和非洲医药合同销售组织市场细分为服务、模块、治疗领域、最终用户和国家。

基于服务,中东和非洲医药合同销售组织市场分为商业服务和非商业服务。商业服务部门在 2022 年占据了中东和非洲医药合同销售组织市场的更大份额。

基于模块,中东和非洲医药合同销售组织市场分为联合模块和专用模块。 2022 年,联合模块部门在中东和非洲医药合同销售组织市场中占有较大份额。

根据治疗领域,中东和非洲医药合同销售组织市场细分为心血管疾病、肿瘤学、代谢疾病、神经病学、骨科疾病、传染病等。2022 年,肿瘤学部门在中东和非洲医药合同销售组织市场中占有最大份额。

根据最终用户,中东和非洲医药合同销售组织市场分为生物制药公司和制药公司。2022 年,制药公司部门在中东和非洲医药合同销售组织市场中占有较大份额。

根据国家/地区,中东和非洲医药合同销售组织市场细分为沙特阿拉伯、南非、阿联酋和中东及非洲其他地区。 2022 年,沙特阿拉伯在中东和非洲医药合同销售组织市场占据主导地位。

Aenova Holding GmbH、IQVIA Holdings Inc、辉瑞公司和 Syneos Health Inc 是中东和非洲医药合同销售组织市场的一些领先公司。

Table of Content

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Middle East & Africa PEST Analysis

5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Integration of Digital Technologies

5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products

5.2 Key Market Restraints

5.2.1 Quality Issues Associated with Outsourcing

5.3 Key Market Opportunities

5.3.1 Rising Use of Telemedicine and Remote Detailing

5.4 Key Future Trends

5.4.1 Expansion in Emerging Markets

5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - Middle East & Africa Analysis

6.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview

7.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

7.3 Commercial Services

7.3.1 Overview

7.3.2 Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Non-Commercial Services

7.4.1 Overview

7.4.2 Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview

8.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

8.3 Syndicated Modules

8.3.1 Overview

8.3.2 Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Dedicated Modules

8.4.1 Overview

8.4.2 Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview

9.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

9.3 Cardiovascular Disorders

9.3.1 Overview

9.3.2 Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Metabolic Disorders

9.5.1 Overview

9.5.2 Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Neurology

9.6.1 Overview

9.6.2 Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.7 Orthopaedic Diseases

9.7.1 Overview

9.7.2 Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.8 Infectious Diseases

9.8.1 Overview

9.8.2 Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

10.3 Biopharmaceutical Companies

10.3.1 Overview

10.3.2 Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Pharmaceutical Companies

10.4.1 Overview

10.4.2 Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Country

11.1.1 Saudi Arabia

11.1.1.1 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.3 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.4 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.5 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.2 UAE

11.1.2.1 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.2.2 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.2.3 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.2.4 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.2.5 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.3 South Africa

11.1.3.1 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.3.2 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.3.3 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.3.4 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.3.5 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.4 Rest of Middle East & Africa

11.1.4.1 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.4.2 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.4.3 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.4.4 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.4.5 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview

12.2 Growth Strategies

12.2.1 Overview

13. Company Profiles

13.1 IQVIA Holdings Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Syneos Health Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Aenova Holding GmbH

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Pfizer Inc

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

 

 

?

List of Tables

Table 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation

Table 2. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 3. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 4. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 5. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 6. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 7. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 8. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 9. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 10. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 11. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 12. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 13. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 15. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 16. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 18. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market

Table 19. Glossary of Terms, Middle East & Africa Pharmaceutical Contract Sales Organizations Market

?

List of Figures

Figure 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation, By Country

Figure 2. Middle East & Africa - PEST Analysis

Figure 3. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

Figure 6. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

Figure 7. Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

Figure 10. Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

Figure 13. Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 21. Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 24. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)

Figure 25. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

1. Aenova Holding GmbH

 

2. IQVIA Holdings Inc

3. Pfizer Inc

4. Syneos Health Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440